| Product Code: ETC7548803 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Neuroendocrine Tumors Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Neuroendocrine Tumors Market Revenues & Volume, 2021 & 2031F |
3.3 India Neuroendocrine Tumors Market - Industry Life Cycle |
3.4 India Neuroendocrine Tumors Market - Porter's Five Forces |
3.5 India Neuroendocrine Tumors Market Revenues & Volume Share, By Classification, 2021 & 2031F |
3.6 India Neuroendocrine Tumors Market Revenues & Volume Share, By Site, 2021 & 2031F |
3.7 India Neuroendocrine Tumors Market Revenues & Volume Share, By Grade, 2021 & 2031F |
3.8 India Neuroendocrine Tumors Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.9 India Neuroendocrine Tumors Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.10 India Neuroendocrine Tumors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 India Neuroendocrine Tumors Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Neuroendocrine Tumors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neuroendocrine tumors in India |
4.2.2 Growing awareness about early diagnosis and treatment options |
4.2.3 Advancements in diagnostic technologies for neuroendocrine tumors |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities in certain regions of India |
4.3.2 High cost of neuroendocrine tumor treatments |
4.3.3 Lack of skilled healthcare professionals for managing neuroendocrine tumors |
5 India Neuroendocrine Tumors Market Trends |
6 India Neuroendocrine Tumors Market, By Types |
6.1 India Neuroendocrine Tumors Market, By Classification |
6.1.1 Overview and Analysis |
6.1.2 India Neuroendocrine Tumors Market Revenues & Volume, By Classification, 2021- 2031F |
6.1.3 India Neuroendocrine Tumors Market Revenues & Volume, By Functional Net, 2021- 2031F |
6.1.4 India Neuroendocrine Tumors Market Revenues & Volume, By Non-Functional Net, 2021- 2031F |
6.2 India Neuroendocrine Tumors Market, By Site |
6.2.1 Overview and Analysis |
6.2.2 India Neuroendocrine Tumors Market Revenues & Volume, By Lung, 2021- 2031F |
6.2.3 India Neuroendocrine Tumors Market Revenues & Volume, By Pancreas, 2021- 2031F |
6.2.4 India Neuroendocrine Tumors Market Revenues & Volume, By Gastrointestinal Tract (GI), 2021- 2031F |
6.2.5 India Neuroendocrine Tumors Market Revenues & Volume, By Appendicular, 2021- 2031F |
6.3 India Neuroendocrine Tumors Market, By Grade |
6.3.1 Overview and Analysis |
6.3.2 India Neuroendocrine Tumors Market Revenues & Volume, By Grade 1, 2021- 2031F |
6.3.3 India Neuroendocrine Tumors Market Revenues & Volume, By Low-Grade Tumor, 2021- 2031F |
6.3.4 India Neuroendocrine Tumors Market Revenues & Volume, By Grade 2, 2021- 2031F |
6.3.5 India Neuroendocrine Tumors Market Revenues & Volume, By Intermediate-Grade Tumor, 2021- 2031F |
6.3.6 India Neuroendocrine Tumors Market Revenues & Volume, By Grade 3, 2021- 2031F |
6.3.7 India Neuroendocrine Tumors Market Revenues & Volume, By High-Grade Tumor, 2021- 2031F |
6.4 India Neuroendocrine Tumors Market, By Type |
6.4.1 Overview and Analysis |
6.4.2 India Neuroendocrine Tumors Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.4.3 India Neuroendocrine Tumors Market Revenues & Volume, By Treatment, 2021- 2031F |
6.5 India Neuroendocrine Tumors Market, By Product |
6.5.1 Overview and Analysis |
6.5.2 India Neuroendocrine Tumors Market Revenues & Volume, By Somatostatin Analogs, 2021- 2031F |
6.5.3 India Neuroendocrine Tumors Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.5.4 India Neuroendocrine Tumors Market Revenues & Volume, By Tyrosine Kinase Inhibitors, 2021- 2031F |
6.5.5 India Neuroendocrine Tumors Market Revenues & Volume, By mTOR Inhibitors, 2021- 2031F |
6.5.6 India Neuroendocrine Tumors Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.5.7 India Neuroendocrine Tumors Market Revenues & Volume, By Antimetabolites, 2021- 2031F |
6.5.8 India Neuroendocrine Tumors Market Revenues & Volume, By Natural Products, 2021- 2031F |
6.5.9 India Neuroendocrine Tumors Market Revenues & Volume, By Natural Products, 2021- 2031F |
6.6 India Neuroendocrine Tumors Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 India Neuroendocrine Tumors Market Revenues & Volume, By Oral, 2021- 2031F |
6.6.3 India Neuroendocrine Tumors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.7 India Neuroendocrine Tumors Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 India Neuroendocrine Tumors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 India Neuroendocrine Tumors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.7.4 India Neuroendocrine Tumors Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.7.5 India Neuroendocrine Tumors Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.7.6 India Neuroendocrine Tumors Market Revenues & Volume, By Others, 2021- 2031F |
6.8 India Neuroendocrine Tumors Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 India Neuroendocrine Tumors Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.8.3 India Neuroendocrine Tumors Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.8.4 India Neuroendocrine Tumors Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.8.5 India Neuroendocrine Tumors Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.8.6 India Neuroendocrine Tumors Market Revenues & Volume, By Other, 2021- 2031F |
7 India Neuroendocrine Tumors Market Import-Export Trade Statistics |
7.1 India Neuroendocrine Tumors Market Export to Major Countries |
7.2 India Neuroendocrine Tumors Market Imports from Major Countries |
8 India Neuroendocrine Tumors Market Key Performance Indicators |
8.1 Number of new diagnostic centers specializing in neuroendocrine tumors |
8.2 Adoption rate of advanced treatment modalities for neuroendocrine tumors |
8.3 Percentage increase in early-stage diagnosis of neuroendocrine tumors |
8.4 Patient satisfaction scores with neuroendocrine tumor care services |
8.5 Number of clinical trials for innovative neuroendocrine tumor treatments in India |
9 India Neuroendocrine Tumors Market - Opportunity Assessment |
9.1 India Neuroendocrine Tumors Market Opportunity Assessment, By Classification, 2021 & 2031F |
9.2 India Neuroendocrine Tumors Market Opportunity Assessment, By Site, 2021 & 2031F |
9.3 India Neuroendocrine Tumors Market Opportunity Assessment, By Grade, 2021 & 2031F |
9.4 India Neuroendocrine Tumors Market Opportunity Assessment, By Type, 2021 & 2031F |
9.5 India Neuroendocrine Tumors Market Opportunity Assessment, By Product, 2021 & 2031F |
9.6 India Neuroendocrine Tumors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 India Neuroendocrine Tumors Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 India Neuroendocrine Tumors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Neuroendocrine Tumors Market - Competitive Landscape |
10.1 India Neuroendocrine Tumors Market Revenue Share, By Companies, 2024 |
10.2 India Neuroendocrine Tumors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here